Genetics of IL28B and HCV—response to infection and treatment
- 29 May 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Gastroenterology & Hepatology
- Vol. 9 (7), 406-417
- https://doi.org/10.1038/nrgastro.2012.101
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- IL28B inhibits hepatitis C virus replication through the JAK–STAT pathwayJournal of Hepatology, 2011
- IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCCJournal of Hepatology, 2011
- Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patientsHepatology, 2010
- IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in MacaquesMolecular Therapy, 2010
- IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis CHepatology, 2010
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionHepatology, 2010
- Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionHepatology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005